News Center



Home News Center Events

Alumnus Sharing: Shoot for Star at BiMBA

Nov 16-2023   



Event Information

Time: 19:00-21:00, November 16 (Thursday), 2023

Venue: Meeting Room C, 5th Floor, WeWork, PCCW Center (Jia No.2, Workers’ Stadium North Road, Chaoyang District, Beijing). Live streaming available.

Agenda:

19:00-19:30 Introduction of MBA programs at NSD

19:30-20:30 MBA alumni sharing

20:30-21:00 Q&A / free exchanges

Sign up

 

Alumnus speakers

Mr. Meng Ziyan, 2022 PKU-UCL full-time MBA. Mr. Meng has five years’ experiences in launching and managing startups. He has been involved in the establishment of three firms which respectively are in construction material industry, agriculture, and education and training. The three companies have successfully built own brands in their respective fields. Mr. Meng has acquired expertise in sales, marketing, and branding, along with rich management experience. Currently he is general manager of Beijing Haoyuan, a manufacturer of new building materials, and director of Qian Mu Farm.

 

Ms. Peng Weiyan, 2021 PKU-UCL part-time MBA, Master of Phytobiology from Leibniz University Hannover, Germany. Ms. Peng has worked in genome sequencing for nearly ten years in jobs related to marketing, sales, and technology. She has left her marks on the upstream and downstream of the industry, and accumulated abundant overseas and domestic experiences in business development and management. Currently she is senior marketing manager for research applications at Illumina, a global leader in genome sequencing and semi-conductor technology.

 

Mr. Wang Zhiqiu, 2022 PKU-Vlerick part-time MBA class head. Mr. Wang has ten years’ experiences creating startups and is currently founder and CEO of Grape Union Medical Technology. His company offers AI and digital solutions and technological services to the healthcare industry. Mr. Wang has been involved in the deployment of the digital collaboration platforms of National Health Commission, National Healthcare Security Administration, and leading hospitals and publicly listed pharmaceutical firms.

 

Alumnus Sharing: Shoot for Star at BiMBA

Nov 16-2023   



Event Information

Time: 19:00-21:00, November 16 (Thursday), 2023

Venue: Meeting Room C, 5th Floor, WeWork, PCCW Center (Jia No.2, Workers’ Stadium North Road, Chaoyang District, Beijing). Live streaming available.

Agenda:

19:00-19:30 Introduction of MBA programs at NSD

19:30-20:30 MBA alumni sharing

20:30-21:00 Q&A / free exchanges

Sign up

 

Alumnus speakers

Mr. Meng Ziyan, 2022 PKU-UCL full-time MBA. Mr. Meng has five years’ experiences in launching and managing startups. He has been involved in the establishment of three firms which respectively are in construction material industry, agriculture, and education and training. The three companies have successfully built own brands in their respective fields. Mr. Meng has acquired expertise in sales, marketing, and branding, along with rich management experience. Currently he is general manager of Beijing Haoyuan, a manufacturer of new building materials, and director of Qian Mu Farm.

 

Ms. Peng Weiyan, 2021 PKU-UCL part-time MBA, Master of Phytobiology from Leibniz University Hannover, Germany. Ms. Peng has worked in genome sequencing for nearly ten years in jobs related to marketing, sales, and technology. She has left her marks on the upstream and downstream of the industry, and accumulated abundant overseas and domestic experiences in business development and management. Currently she is senior marketing manager for research applications at Illumina, a global leader in genome sequencing and semi-conductor technology.

 

Mr. Wang Zhiqiu, 2022 PKU-Vlerick part-time MBA class head. Mr. Wang has ten years’ experiences creating startups and is currently founder and CEO of Grape Union Medical Technology. His company offers AI and digital solutions and technological services to the healthcare industry. Mr. Wang has been involved in the deployment of the digital collaboration platforms of National Health Commission, National Healthcare Security Administration, and leading hospitals and publicly listed pharmaceutical firms.